Dr Reddys launches generic version of Hemabate injection indicated for abortion in US

Carboprost Tromethamine injection for aborting a pregnancy is a generic version of Pfizer's Hemabate injection in the strength of 250 mcg/mL, Dr Reddys said.

New Delhi: Dr Reddy's Laboratories on Wednesday said it has launched in the US generic Carboprost Tromethamine injection used for aborting a pregnancy.

The company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market, the pharma major said in a filing to BSE.

The product is a generic version of Pfizer's Hemabate injection in the strength of 250 mcg/mL, it added.

"We are pleased to be first-to-market with this product that has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said.

Read Also: Dr Reddys unveils cancer drug Bortezomib in the US

With a CGT designation, the company has 180-day CGT exclusivity to market this product, he added.

As per IQVIA Health data, Hemabate injection, 250 mcg/mL brand had US sales of approximately USD 55 million MAT for the twelve months ended April 2019, Dr Reddy's Labs said.

Read Also: Chinese strategy: Dr Reddy’s outsources part manufacturing to local parties